Supplementary Table S1 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001

Abstract

<p>Summary of Exposure to ZKAB001, All Treated Patient Population</p>